VC
PRAX icon

Vivo Capital’s Praxis Precision Medicines PRAX Stock Holding History

Vivo Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.8M Sell
271,116
-67,779
-20% -$21.5M 8.29% 2
2026
Q1 		$109M Buy
338,895
+10,000
+3% +$3.09M 9.08% 2
2025
Q4 		$96.9M Buy
328,895
+130,000
+65% +$24.2M 6.27% 3
2025
Q3 		$10.5M Buy
198,895
+31,295
+19% +$1.52M 0.85% 32
2025
Q2 		$7.05M Buy
+167,600
New +$6.38M 0.72% 29

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vivo Capital's PRAX Position: Q2 2026 in Review

Vivo Capital reduced its Praxis Precision Medicines (PRAX) stake by 20% in Q2 2026, selling an estimated $21.5M and leaving 271,116 shares worth $90.8M. The position accounts for 8.29% of the portfolio, ranked #2.

Vivo Capital first reported a position in PRAX in Q2 2025 and has held it in 5 quarters since. The position peaked at $109M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Vivo Capital held 271,116 shares of Praxis Precision Medicines worth $90.8M as of Q2 2026.
  • Vivo Capital sold 67,779 Praxis Precision Medicines shares in Q2 2026, an estimated $21.5M.
  • Praxis Precision Medicines made up 8.29% of Vivo Capital's portfolio in Q2 2026, its #2 holding.
  • Vivo Capital first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 5 quarters since.
  • Vivo Capital's Praxis Precision Medicines position peaked at $109M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.